PE-22-28 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of PE-22-28 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF102025052

Key analytical results include:

• Assay Content: 9.93 mg
• Identification – Retention Time: 0.998
• Identification – Spectrum: 999
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: detected but below 0.01 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

PE-22-28 is a synthetic peptide research compound frequently investigated in controlled laboratory environments studying peptide-mediated biological signalling and cellular regulatory mechanisms.

The compound belongs to a class of short-chain experimental peptides designed for biochemical research exploring intracellular signalling pathways and receptor-mediated interactions.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves structural stability and allows researchers to reconstitute the peptide for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, PE-22-28 is utilized in experimental peptide research models investigating molecular signalling processes and peptide-based regulatory systems.

Compound Overview

PE-22-28 is an experimental synthetic peptide developed for use in biochemical and molecular biology research environments.

Short-chain peptides such as PE-22-28 are frequently studied for their potential interactions with cellular receptors, signalling proteins and regulatory pathways involved in intracellular communication.

Research involving peptides of this category often focuses on how specific amino acid sequences interact with cellular systems and influence signalling cascades within experimental models.

Because of the highly controlled structure of synthetic peptides, they provide researchers with precise molecular tools for investigating biological signalling mechanisms.

Historical Background and Scientific Context

Peptide-based biochemical research expanded rapidly during the late twentieth century as advances in peptide synthesis technologies made it possible to create highly specific experimental peptide sequences.

During the 1980s and 1990s the development of solid-phase peptide synthesis enabled laboratories to design short-chain peptides used to study receptor signalling, enzyme activity and intracellular regulatory processes.

Over time, synthetic peptides became widely used tools in molecular biology research due to their ability to mimic or modulate naturally occurring signalling molecules.

Today compounds such as PE-22-28 are investigated within experimental models examining peptide signalling systems and molecular regulatory networks.

Mechanistic Focus in Research

Within experimental laboratory settings, PE-22-28 is often studied in relation to peptide-mediated signalling pathways and molecular regulatory mechanisms.

Research investigations commonly explore the compound in experimental models examining:

• Peptide signalling pathway interaction
• Receptor-mediated cellular communication
• Intracellular signalling cascade modulation
• Molecular regulatory pathway modelling
• Comparative peptide activity analysis
• Biochemical peptide-receptor interaction studies
• Cellular regulatory network research

These experimental models allow scientists to investigate molecular signalling mechanisms that influence cellular communication and biochemical regulation.

Research Applications

In controlled research environments, PE-22-28 may be utilised in experimental models designed to explore peptide signalling and intracellular regulatory systems.

Examples of research applications include:

• Peptide signalling pathway investigation
• Cell communication studies
• Receptor interaction analysis
• Molecular peptide research
• Comparative peptide compound evaluation
• Intracellular regulatory network modelling
• Controlled in vitro peptide studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 9.93 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin detected but below 0.01 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.